CLINICAL_TRIALS
trial_result
· 2017-07-13
Clinical Trial Update: Hepatic Xenetix-CT Perfusion [Phase 4]
Summary
Phase 4 trial update for hepatic Xenetix-CT Perfusion in hepatocellular carcinoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guerbet | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2017-07-13